Arlington Partners’s Steris STE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-443
Closed -$81.8K 597
2022
Q4
$81.8K Hold
443
0.01% 178
2022
Q3
$74K Hold
443
0.03% 164
2022
Q2
$91K Hold
443
0.03% 176
2022
Q1
$107K Hold
443
0.03% 174
2021
Q4
$108K Buy
+443
New +$101K 0.03% 193

Other funds holding STE

Arlington Partners's STE Position: Q1 2023 in Review

Arlington Partners sold out of Steris (STE) in Q1 2023, closing a stake of 443 shares — an estimated $81.8K sold.

Arlington Partners first reported a position in STE in Q4 2021 and held it in 5 quarters. The position peaked at $108K in Q4 2021. 621 funds tracked by Wall St. Rank hold STE as of Q1 2023.

  • Arlington Partners reported no remaining Steris position as of Q1 2023 after selling out during the quarter.
  • Arlington Partners sold 443 Steris shares in Q1 2023, an estimated $81.8K.
  • Arlington Partners first reported a position in Steris in Q4 2021 and held it in 5 quarters.
  • Arlington Partners's Steris position peaked at $108K in Q4 2021.
  • 621 funds tracked by Wall St. Rank held Steris as of Q1 2023.

Based on Arlington Partners's 13F filing for Q1 2023, filed 26 Apr 2023.